Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies

Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies have?

Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies has 194 citations in the OpenAlex counts ScholarIQ stores.

When was Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies published?

Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies has 2019 year in the ScholarIQ index.

What is the open-access status of Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies?

Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies has hybrid oa status in the ScholarIQ index.

What is the DOI of Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies?

The DOI for Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies is on the source record.

What is the PMID of Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies?

The PMID for Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies is on the source record.

What is the OpenAlex record for Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies?

The OpenAlex for Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies is on the source record.